GSK Lifts Outlook as Specialty Medicines Drive Profit Beat Amid Tariff Uncertainty
GSK upgrades 2025 outlook after strong Q2, led by Specialty Medicines growth and R&D momentum.
GSK
Stay informed on GSK PLC (GSK) with the latest news, analysis, forecasts, and opinion pieces. Track GSK shares and market performance, all in one place.
GSK Blindsided as Blenrep Stumbles Again in the US, Shares Dive
GSK shares sink after FDA panel rejects Blenrep cancer drug, raising doubts over turnaround strategy.